KRAS and GNAS are the most commonly mutated oncogenes contributing to pancreatic cancer, and these mutations tend to occur early on in branch duct IPMN tumorigenesis (Table 1) [21]. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.